Effect of cbfa1 on osteogenic differentiation of mesenchymal stem cells under hypoxia condition

International Journal of Clinical and Experimental Medicine

Volumn 7, Issue 3, 2014, Pages 540-548

  Li, Z Hangua ^a   Liao, Wen ^b   Zhao, Qiang ^c   Huan, Tang ^a   Feng, Pan ^a   Wei, Xia ^c   Yi, Yang ^d   Shao, Ning Sheng ^c  

^a RENMIN HOSPITAL OF WUHAN UNIVERSITY   (China)

^b HUBEI UNIVERSITY OF CHINESE MEDICINE   (China)

^c BEIJING INSTITUTE OF MICROBIOLOGY AND EPIDEMIOLOGY   (China)

^d WUHAN SPORTS UNIVERSITY   (China)

Author keywords

Core binding factor alpha l; Hypoxia; Mesenchymal stem cell

Indexed keywords

ALKALINE PHOSPHATASE; COMPLEMENTARY DNA; MESSENGER RNA; OSTEOPONTIN; PROCOLLAGEN C PROTEINASE; TETRACYCLINE; TRANSCRIPTION FACTOR RUNX2; VASCULOTROPIN;

ADULT; ANIMAL CELL; ANIMAL TISSUE; ARTICLE; AVASCULAR NECROSIS; CELL DIFFERENTIATION; CELL STRUCTURE; CONTROLLED STUDY; DNA EXTRACTION; FLUORESCENCE MICROSCOPE; GENE EXPRESSION; GENETIC TRANSFECTION; HYPOXIA; MESENCHYMAL STEM CELL; MTT ASSAY; NONHUMAN; OPTICAL DENSITY; OSTEOBLAST; PROTEIN EXPRESSION; RABBIT; REAL TIME POLYMERASE CHAIN REACTION; REVERSE TRANSCRIPTION;

EID: 84897519178     PISSN: None     EISSN: 19405901     Source Type: Journal    
DOI: None     Document Type: Article

References (30)

1. Jager M, Hernigou P, Zilkens C, Herten M, Li X, Fischer J and Krauspe R. Cell therapy in bone healing disorders. Orthop Rev (Pavia) 2010; 2: e20.
2. Yan ZQ, Chen YS, Li WJ, Yang Y, Huo JZ, Chen ZR, Shi JH and Ge JB. Treatment of osteonecrosis of the femoral head by percutaneous decompression and autologous bone marrow mononuclear cell infusion. Chin J Traumatol 2006; 9: 3-7.
3. Sen RK. Management of avascular necrosis of femoral head at pre-collapse stage. Indian J Orthop 2009; 43: 6-16.
4. Muller I, Vaegler M, Holzwarth C, Tzaribatchev N, Pfister SM, Schutt B, Reize P, Greil J, Handgretinger R and Rudert M. Secretion of angiogenic proteins by human multipotent mesenchymal stromal cells and their clinical potential in the treatment of avascular osteonecrosis. Leukemia 2008; 22: 2054-2061.
5. Tzaribachev N, Vaegler M, Schaefer J, Reize P, Rudert M, Handgretinger R and Muller I. Mesenchymal stromal cells: a novel treatment option for steroid-induced avascular osteonecrosis. Isr Med Assoc J 2008; 10: 232-234.
6. D'Ippolito G, Diabira S, Howard GA, Roos BA and Schiller PC. Low oxygen tension inhibits osteogenic differentiation and enhances stemness of human MIAMI cells. Bone 2006; 39: 513-522.
7. He J, Genetos DC, Yellowley CE and Leach JK. Oxygen tension differentially influences osteogenic differentiation of human adipose stem cells in 2D and 3D cultures. J Cell Biochem 2010; 110: 87-96.
8. Potier E, Ferreira E, Andriamanalijaona R, Pujol JP, Oudina K, Logeart-Avramoglou D and Petite H. Hypoxia affects mesenchymal stromal cell osteogenic differentiation and angiogenic factor expression. Bone 2007; 40: 1078-1087.
9. Malladi P, Xu Y, Chiou M, Giaccia AJ and Longaker MT. Effect of reduced oxygen tension on chondrogenesis and osteogenesis in adipose-derived mesenchymal cells. Am J Physiol Cell Physiol 2006; 290: C1139-1146.
10. Holzwarth C, Vaegler M, Gieseke F, Pfister SM, Handgretinger R, Kerst G and Muller I. Low physiologic oxygen tensions reduce proliferation and differentiation of human multipotent mesenchymal stromal cells. BMC Cell Biol 2010; 11: 11.
11. Geng YJ. Molecular mechanisms for cardiovascular stem cell apoptosis and growth in the hearts with atherosclerotic coronary disease and ischemic heart failure. Ann N Y Acad Sci 2003; 1010: 687-697.
12. Salim A, Nacamuli RP, Morgan EF, Giaccia AJ and Longaker MT. Transient changes in oxygen tension inhibit osteogenic differentiation and Runx2 expression in osteoblasts. J Biol Chem 2004; 279: 40007-40016.
13. Lennon DP, Edmison JM and Caplan AI. Cultivation of rat marrow-derived mesenchymal stem cells in reduced oxygen tension: effects on in vitro and in vivo osteochondrogenesis. J Cell Physiol 2001; 187: 345-355.
14. Tsai CC, Yew TL, Yang DC, Huang WH and Hung SC. Benefits of hypoxic culture on bone marrow multipotent stromal cells. Am J Blood Res 2012; 2: 148-159.
15. Das R, Jahr H, van Osch GJ and Farrell E. The role of hypoxia in bone marrow-derived mesenchymal stem cells: considerations for regenerative medicine approaches. Tissue Eng Part B Rev 2010; 16: 159-168.
16. Huang YC, Zhu HM, Cai JQ, Huang YZ, Xu J, Zhou Y, Chen XH, Li XQ, Yang ZM and Deng L. Hypoxia inhibits the spontaneous calcification of bone marrow-derived mesenchymal stem cells. J Cell Biochem 2012; 113: 1407-1415.
17. Sheehy EJ, Buckley CT and Kelly DJ. Oxygen tension regulates the osteogenic, chondrogenic and endochondral phenotype of bone marrow derived mesenchymal stem cells. Biochem Biophys Res Commun 2012; 417: 305-310.
18. Pattappa G, Thorpe SD, Jegard NC, Heywood HK, de Bruijn JD and Lee DA. Continuous and uninterrupted oxygen tension influences the colony formation and oxidative metabolism of human mesenchymal stem cells. Tissue Eng Part C Methods 2013; 19: 68-79.
19. Frendo JL, Xiao G, Fuchs S, Franceschi RT, Karsenty G and Ducy P. Functional hierarchy between two OSE2 elements in the control of osteocalcin gene expression in vivo. J Biol Chem 1998; 273: 30509-30516.
20. Yoshida CA, Furuichi T, Fujita T, Fukuyama R, Kanatani N, Kobayashi S, Satake M, Takada K and Komori T. Core-binding factor beta interacts with Runx2 and is required for skeletal development. Nat Genet 2002; 32: 633-638.
21. Selvamurugan N, Brown RJ and Partridge NC. Regulation of collagenase-3 gene expression in osteoblastic and non-osteoblastic cell lines. J Cell Biochem 2000; 79: 182-190.
22. Komori T. A fundamental transcription factor for bone and cartilage. Biochem Biophys Res Commun 2000; 276: 813-816.
23. Zheng H, Guo Z, Ma Q, Jia H and Dang G. Cbfa1/osf2 transduced bone marrow stromal cells facilitate bone formation in vitro and in vivo. Calcif Tissue Int 2004; 74: 194-203.
24. Zhao Z, Zhao M, Xiao G and Franceschi RT. Gene transfer of the Runx2 transcription factor enhances osteogenic activity of bone marrow stromal cells in vitro and in vivo. Mol Ther 2005; 12: 247-253.
25. Zhao Z, Wang Z, Ge C, Krebsbach P and Franceschi RT. Healing cranial defects with AdRunx2-transduced marrow stromal cells. J Dent Res 2007; 86: 1207-1211.
26. Li ZH, Liao W, Cui XL, Zhao Q, Liu M, Chen YH, Liu TS, Liu NL, Wang F, Yi Y and Shao NS. Intravenous transplantation of allogeneic bone marrow mesenchymal stem cells and its directional migration to the necrotic femoral head. Int J Med Sci 2011; 8: 74-83.
27. Gordillo GM and Sen CK. Revisiting the essential role of oxygen in wound healing. Am J Surg 2003; 186: 259-263.
28. Ranera B, Remacha AR, Alvarez-Arguedas S, Romero A, Vazquez FJ, Zaragoza P, Martin-Burriel I and Rodellar C. Effect of hypoxia on equine mesenchymal stem cells derived from bone marrow and adipose tissue. BMC Vet Res 2012; 8: 142.
29. Lee JH and Kemp DM. Human adipose-derived stem cells display myogenic potential and perturbed function in hypoxic conditions. Biochem Biophys Res Commun 2006; 341: 882-888.
30. Komori T and Kishimoto T. Cbfa1 in bone development. Curr Opin Genet Dev 1998; 8: 494-499.